Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Drugs For Malaria market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 8.5% during the forecast period.
This report presents the market size and development trends by detailing the Drugs For Malaria market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Drugs For Malaria market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Drugs For Malaria industry and will help you to build a panoramic view of the industrial development.
Drugs For Malaria Market, By Type:
Quinine
Chloroquine
Amodiaquine
Pyrimethamine
Sulfonamide
Others
Drugs For Malaria Market, By Application:
Treatment
Prevention
Resistance
Others
Some of the leading players are as follows:
Novartis
IPCA Laboratories
Ajanta Pharma
Guilin Pharmaceutical
Mylan Labs
Cipla
Sanofi Aventis
GlaxoSmithKline
Roche
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Drugs For Malaria Market: Technology Type Analysis
-
4.1 Drugs For Malaria Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Drugs For Malaria Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Quinine
4.3.2 Chloroquine
4.3.3 Amodiaquine
4.3.4 Pyrimethamine
4.3.5 Sulfonamide
4.3.6 Others
5 Drugs For Malaria Market: Product Analysis
-
5.1 Drugs For Malaria Product Market Share Analysis, 2018 & 2026
-
5.2 Drugs For Malaria Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Drugs For Malaria Market: Application Analysis
-
6.1 Drugs For Malaria Application Market Share Analysis, 2018 & 2026
-
6.2 Drugs For Malaria Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Treatment
6.3.2 Prevention
6.3.3 Resistance
6.3.4 Others
7 Drugs For Malaria Market: Regional Analysis
-
7.1 Drugs For Malaria Regional Market Share Analysis, 2018 & 2026
-
7.2 Drugs For Malaria Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Novartis
9.1.1 Novartis Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 IPCA Laboratories
9.2.1 IPCA Laboratories Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Ajanta Pharma
9.3.1 Ajanta Pharma Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Guilin Pharmaceutical
9.4.1 Guilin Pharmaceutical Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Mylan Labs
9.5.1 Mylan Labs Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Cipla
9.6.1 Cipla Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 Sanofi Aventis
9.7.1 Sanofi Aventis Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 GlaxoSmithKline
9.8.1 GlaxoSmithKline Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Roche
9.9.1 Roche Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
The List of Tables and Figures (Totals 92 Figures and 126 Tables)
Figure Quinine Drugs For Malaria market, 2015 - 2026 (USD Million)
Figure Chloroquine Drugs For Malaria market, 2015 - 2026 (USD Million)
Figure Amodiaquine Drugs For Malaria market, 2015 - 2026 (USD Million)
Figure Pyrimethamine Drugs For Malaria market, 2015 - 2026 (USD Million)
Figure Sulfonamide Drugs For Malaria market, 2015 - 2026 (USD Million)
Figure Others Drugs For Malaria market, 2015 - 2026 (USD Million)
Figure Treatment market, 2015 - 2026 (USD Million)
Figure Prevention market, 2015 - 2026 (USD Million)
Figure Resistance market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Drugs For Malaria market, by country, 2015 - 2026 (USD Million)
-
Table North America Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table North America Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table North America Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Canada Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Canada Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Europe Drugs For Malaria market, by country, 2015 - 2026 (USD Million)
-
Table Europe Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Europe Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Europe Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Germany Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Germany Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table France Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table France Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Italy Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Italy Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Spain Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Spain Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Drugs For Malaria market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table China Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table China Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Japan Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Japan Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table India Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table India Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Drugs For Malaria market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table MEA Drugs For Malaria market, by country, 2015 - 2026 (USD Million)
-
Table MEA Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table MEA Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table MEA Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Drugs For Malaria market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Drugs For Malaria market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Drugs For Malaria market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Novartis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table IPCA Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Ajanta Pharma Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Guilin Pharmaceutical Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Mylan Labs Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Cipla Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Aventis Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-
